The National Academies’ 2024 Diagnostic Criteria for Long <scp>COVID</scp> : Concerns That Could Affect the Rheumatology Community
Disclosure Form Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Authors
- Leonard H. Calabrese (ORCID: https://orcid.org/0000-0002-1789-4923)
- Kevin L. Winthrop (ORCID: https://orcid.org/0000-0002-3892-6947)
- Cassandra Calabrese (ORCID: https://orcid.org/0000-0002-8773-7739)
- Michael Putman (ORCID: https://orcid.org/0000-0001-9699-4000)
- Zachary S. Wallace (ORCID: https://orcid.org/0000-0003-4708-7038)
- Jeffrey A. Sparks (ORCID: https://orcid.org/0000-0002-5556-4618)
- Alfred H.J. Kim (ORCID: https://orcid.org/0000-0003-4074-0516)
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Oregon Health & Science University (US)
- Medical College of Wisconsin (US)
- Washington University in St. Louis (US)
- Cleveland Clinic Lerner College of Medicine (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- Arthritis & Rheumatology
- Published
- 2025-01-16
- DOI
- https://doi.org/10.1002/art.43114
- Citations
- 3
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 4.17